Ftse Mib
36.200,72
0,24%
DAX
21.394,93
-0,11%
S&P 500
6.101,24
-0,29%
NASDAQ
19.954,30
-0,50%
Bitcoin
101.440,47
-1,20%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ RAPT Therapeutics Inc (RAPT) RAPT Therapeutics Inc (RAPT) Notizie

RAPT Therapeutics Inc

RAPT
1,1888
-0,0012 (-0,10%)
25 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/1/202522:58EDGAR2Form S-3 - Registration statement under Securities Act of..
13/1/202522:17EDGAR2Form 8-K - Current report
09/1/202514:00GLOBERAPT Therapeutics to Present at the 43rd Annual J.P. Morgan..
07/1/202500:38EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
06/1/202522:31EDGAR2Form 8-K - Current report
06/1/202515:22EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
06/1/202514:00GLOBERAPT Therapeutics Names Lori Lyons-Williams Chair of the..
23/12/202422:55EDGAR2Form 8-K - Current report
23/12/202413:16EDGAR2Form 8-K - Current report
23/12/202413:10GLOBERAPT Therapeutics Announces $150 Million Private Placement
23/12/202413:00GLOBERAPT Therapeutics and Shanghai Jemincare Pharmaceutical..
15/11/202423:15EDGAR2Form 8-K - Current report
14/11/202415:39EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202414:03EDGAR2Form 8-K - Current report
12/11/202414:00GLOBERAPT Therapeutics Reports Third Quarter 2024 Financial..
11/11/202414:00GLOBEBased on Recent FDA Feedback RAPT Therapeutics Stops..
08/8/202414:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202414:05EDGAR2Form 8-K - Current report
08/8/202414:00GLOBERAPT Therapeutics Reports Second Quarter 2024 Financial..
19/7/202423:24EDGAR2Form 8-K - Current report
24/5/202400:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202400:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202400:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202422:49EDGAR2Form 8-K - Current report
09/5/202414:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202414:03EDGAR2Form 8-K - Current report
09/5/202414:00GLOBERAPT Therapeutics Reports First Quarter 2024 Financial..
09/4/202418:00GLOBERAPT Therapeutics Announces Promising Results from Phase 2..
07/3/202422:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/3/202414:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202414:03EDGAR2Form 8-K - Current report
07/3/202414:00GLOBERAPT Therapeutics Reports Fourth Quarter and Full Year 2023..
05/3/202422:30GLOBERAPT Therapeutics Announces Multiple Late-Breaking..
22/2/202423:13EDGAR2Form 8-K - Current report
20/2/202422:29EDGAR2Form 8-K - Current report
20/2/202413:30GLOBERAPT Therapeutics Announces Clinical Hold on Studies..
13/2/202414:00GLOBERAPT Therapeutics Bolsters Leadership Team with the..
31/1/202414:00GLOBERAPT Therapeutics to Participate in the Guggenheim..
Apertura: 1,19 Min: 1,15 Max: 1,245
Chiusura: 1,19

La tua Cronologia

NASDAQ
RAPT
RAPT Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network